Danco Laboratories Fights for Mifepristone Access

0:00It's May 2nd. This is U.S. News Today, your AI-powered source for national news. Denkel Laboratories, the maker of the abortion pill, Mythet Prestone, just filed an emergency plea with the U.S. Supreme Court on May 2nd, 2026. They're asking to freeze a federal appeals court order from the 5th Circuit that kills nationwide telehealth and mail order access to the pill. The company warns this could spark immediate chaos for patients and doctors everywhere. Here this week, that 5th Circuit panel sided with Louisiana, reinstating an old rule for in-person pickups that the FDA dropped back in 2,023. The judges said the state has a strong case under the Administrative Procedure Act, and the change was messing with Louisiana's abortion ban plus. Costing Medicaid money on follow-up care. The ruling hits the whole country, not just one state. Folks are fired up on both sides. Louisiana's Attorney General Liz Murrow called it a big win, while critics like legal

1:00experts Steve Ladek say it's a sneaky way around past Supreme. Court limits on nationwide blocks. Groups like the ACLU point out rural folks, low-income patients, and abuse survivors will suffer most since telehealth handled over 27 percent of abortions in early 2025. Now, the other MythreStone maker, Jen Biopro, plans to jump in with its own appeal. The FDA's doing a fresh safety check started last September, but no word on when it'll wrap. This comes after the Supreme Court in 2024, kept access open by tossing a doctor group's challenge for lack of standing. The justices could act fast with a temporary stay and speedy arguments before summer break, keeping the telehealth option alive while they sort the bigger fight. Eyes are on whether this APA angle changes the game from those earlier rulings.